MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • iDoctor
  • Medical Calculators
  • Videos
  • Health Games

cirrhosis regression

Search medical newsFind research, conditions and clinical updates
  • Home
  • cirrhosis regression
打破“不可逆”观念:代谢减重手术后代偿期MASH肝硬化逆转的证据
Posted inClinical Updates Gastroenterology General Surgery

Reversing the Irreversible: Evidence for Cirrhosis Regression in Compensated MASH Cirrhosis Following Metabolic Bariatric Surgery

Posted by By MedXY 11/10/2026
Metabolic bariatric surgery induces significant histologic regression of cirrhosis and fibrosis remodeling in patients with compensated metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis, challenging the notion that cirrhosis is irreversible.
Read More

Take a game break

Explore a few games from MedXY.

Explore all games
  • Evaluating the Use of Vision-Face-Arm-Speech-Time (V-FAST) in Stroke Admissions: A Comparative Study with NIH Stroke Scale and Orthoptist Assessment in an Emergency Department
  • Targeting the Autotaxin/Lysophosphatidic Acid Axis: A Novel Approach to Modulate Bone Loss and Inflammation in Periodontitis
  • Long-term Comparative Outcomes of PCI with Drug-Eluting Stents Versus CABG in Left Main Coronary Artery Disease: Insights from the IRIS-MAIN Registry
  • Middle Lobe Displacement Post Lobectomy in a Child With Congenital Pulmonary Airway Malformation
  • Targeting Nicotinamide N-Methyltransferase: A Novel Approach to Mitigate Fibroblast Activation and Skin Fibrosis in Systemic Sclerosis
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk case report chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation machine learning MASLD mental health Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis public health quality of life randomized clinical trial randomized controlled trial risk stratification SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top